-
1
-
-
48949095214
-
Translational research in pancreatic cancer
-
Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30-June 3, 2008
-
Saif MW. Translational research in pancreatic cancer. Highlights from the '44th ASCO Annual Meeting'. Chicago, IL, USA. May 30-June 3, 2008. JOP 2008;9(4):398-402
-
(2008)
JOP
, vol.9
, Issue.4
, pp. 398-402
-
-
Saif, M.W.1
-
2
-
-
35348864295
-
Pancreatic cancer: Pathogenesis, prevention and treatment
-
DOI 10.1016/j.taap.2006.11.007, PII S0041008X06004212
-
Sarkar FH, Banerjee S, Li Y. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol Appl Pharmacol 2007;224(3):326-336 (Pubitemid 47575667)
-
(2007)
Toxicology and Applied Pharmacology
, vol.224
, Issue.3
, pp. 326-336
-
-
Sarkar, F.H.1
Banerjee, S.2
Li, Y.3
-
3
-
-
33645526144
-
Cancer statistics
-
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56(2):106-130
-
(2006)
CA Cancer J Clin 2006
, vol.56
, Issue.2
, pp. 106-130
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
-
4
-
-
42049116900
-
New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer
-
Diamantidis M, Tsapournas G, Kountouras J, Zavos C. New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer. Curr Mol Med 2008;8(1):12-37
-
(2008)
Curr Mol Med
, vol.8
, Issue.1
, pp. 12-37
-
-
Diamantidis, M.1
Tsapournas, G.2
Kountouras, J.3
Zavos, C.4
-
5
-
-
34548401651
-
Progress on molecular markers of pancreatic cancer
-
DOI 10.1097/MOG.0b013e3282ba5724, PII 0000157420070900000005
-
Grote T, Logsdon CD. Progress on molecular markers of pancreatic cancer. Curr Opin Gastroenterol 2007;23(5):508-514 (Pubitemid 47356736)
-
(2007)
Current Opinion in Gastroenterology
, vol.23
, Issue.5
, pp. 508-514
-
-
Grote, T.1
Logsdon, C.D.2
-
6
-
-
46949096082
-
Caveolin-1: A marker for pancreatic cancer diagnosis
-
DOI 10.1586/14737159.8.4.395
-
Tanase CP. Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn 2008;8(4):395-404 (Pubitemid 351962086)
-
(2008)
Expert Review of Molecular Diagnostics
, vol.8
, Issue.4
, pp. 395-404
-
-
Tanase, C.P.1
-
7
-
-
51349092847
-
Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients
-
Tian M, Cui YZ, Song GH, et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 2008;8:241
-
(2008)
BMC Cancer
, vol.8
, pp. 241
-
-
Tian, M.1
Cui, Y.Z.2
Song, G.H.3
-
8
-
-
34547417096
-
Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia
-
DOI 10.1053/j.seminoncol.2007.05.003, PII S009377540700098X, Pancreatic Cancer
-
Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol 2007;34(4):303-310 (Pubitemid 47176618)
-
(2007)
Seminars in Oncology
, vol.34
, Issue.4
, pp. 303-310
-
-
Goggins, M.1
-
9
-
-
52749099544
-
Pancreatic cancer: A plea for good and comprehensive morphological studies
-
Algul H, Schmid RM. Pancreatic cancer: a plea for good and comprehensive morphological studies. Eur J Gastroenterol Hepatol 2008;20(8):713-715
-
(2008)
Eur J Gastroenterol Hepatol
, vol.20
, Issue.8
, pp. 713-715
-
-
Algul, H.1
Schmid, R.M.2
-
10
-
-
46349104324
-
A mouse to human search for plasma proteome changes associated with pancreatic tumor development
-
DOI 10.1371/journal.pmed.0050123
-
Faca VM, Song KS, Wang H, et al. A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 2008;5(6):e123 (Pubitemid 351919117)
-
(2008)
PLoS Medicine
, vol.5
, Issue.6
, pp. 953-967
-
-
Faca, V.M.1
Song, K.S.2
Wang, H.3
Zhang, Q.4
Krasnoselsky, A.L.5
Newcomb, L.F.6
Plentz, R.R.7
Gurumurthy, S.8
Redston, M.S.9
Pitteri, S.J.10
Pereira-Faca, S.R.11
Ireton, R.C.12
Katayama, H.13
Glukhova, V.14
Phanstiel, D.15
Brenner, D.E.16
Anderson, M.A.17
Misek, D.18
Scholler, N.19
Urban, N.D.20
Barnett, M.J.21
Edelstein, C.22
Goodman, G.E.23
Thornquist, M.D.24
Mcintosh, M.W.25
Depinho, R.A.26
Bardeesy, N.27
Hanash, S.M.28
more..
-
11
-
-
34547638469
-
Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer
-
Salek C, Benesova L, Zavoral M, et al. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer. World J Gastroenterol 2007;13(27):3714-3720 (Pubitemid 47202169)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.27
, pp. 3714-3720
-
-
Salek, C.1
Benesova, L.2
Zavoral, M.3
Nosek, V.4
Kasperova, L.5
Ryska, M.6
Strnad, R.7
Traboulsi, E.8
Minarik, M.9
-
12
-
-
33646550512
-
Molecular biomarkers: Their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer
-
DOI 10.1158/1535-7163.MCT-06-0005
-
Jimeno A, Hidalgo M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther 2006;5(4):787-796 (Pubitemid 43724577)
-
(2006)
Molecular Cancer Therapeutics
, vol.5
, Issue.4
, pp. 787-796
-
-
Jimeno, A.1
Hidalgo, M.2
-
13
-
-
61449119672
-
Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer
-
El Maalouf G, Le Tourneau C, Batty GN, et al. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer. Cancer Treat Rev 2008;35(2):167-174
-
(2008)
Cancer Treat Rev
, vol.35
, Issue.2
, pp. 167-174
-
-
El Maalouf, G.1
Le Tourneau, C.2
Batty, G.N.3
-
14
-
-
65549110878
-
Diagnostic and prognostic biomarkers in pancreatic carcinoma
-
Liang JJ, Kimchi ET, Staveley-O'Carroll KF, Tan D. Diagnostic and prognostic biomarkers in pancreatic carcinoma. Int J Clin Exp Pathol 2009;2(1):1-10
-
(2009)
Int J Clin Exp Pathol
, vol.2
, Issue.1
, pp. 1-10
-
-
Liang, J.J.1
Kimchi, E.T.2
Staveley-O'Carroll, K.F.3
Tan, D.4
-
15
-
-
36749038370
-
Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma
-
DOI 10.1007/s00534-006-1184-3
-
Fujioka S, Misawa T, Okamoto T, et al. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg 2007;14(6):539-544 (Pubitemid 350201463)
-
(2007)
Journal of Hepato-Biliary-Pancreatic Surgery
, vol.14
, Issue.6
, pp. 539-544
-
-
Fujioka, S.1
Misawa, T.2
Okamoto, T.3
Gocho, T.4
Futagawa, Y.5
Ishida, Y.6
Yanaga, K.7
-
16
-
-
33947668471
-
Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer
-
Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007;33(3):266-270
-
(2007)
Eur J Surg Oncol
, vol.33
, Issue.3
, pp. 266-270
-
-
Goonetilleke, K.S.1
Siriwardena, A.K.2
-
17
-
-
37049033867
-
Early detection and biomarkers in pancreatic cancer
-
Misek DE, Patwa TH, Lubman DM, Simeone DM. Early detection and biomarkers in pancreatic cancer. J Natl Compr Canc Netw 2007;5(10):1034-1041 (Pubitemid 350247711)
-
(2007)
JNCCN Journal of the National Comprehensive Cancer Network
, vol.5
, Issue.10
, pp. 1034-1041
-
-
Misek, D.E.1
Patwa, T.H.2
Lubman, D.M.3
Simeone, D.M.4
-
18
-
-
33745552215
-
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
-
DOI 10.1200/JCO.2005.05.3934
-
Ferrone CR, Finkelstein DM, Thayer SP, et al. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol 2006;24(18):2897-2902 (Pubitemid 46630592)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2897-2902
-
-
Ferrone, C.R.1
Finkelstein, D.M.2
Thayer, S.P.3
Muzikansky, A.4
Fernandez-Del Castillo, C.5
Warshaw, A.L.6
-
19
-
-
49749088333
-
Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19-9 levels in pancreatic cancer
-
Grote T, Siwak DR, Fritsche HA, et al. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer. Proteomics 2008;8(15):3051-3060
-
(2008)
Proteomics
, vol.8
, Issue.15
, pp. 3051-3060
-
-
Grote, T.1
Siwak, D.R.2
Fritsche, H.A.3
-
20
-
-
33748941924
-
Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer
-
Kilic M, Gocmen E, Tez M, et al. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer. Can J Surg 2006;49(4):241-244 (Pubitemid 44432800)
-
(2006)
Canadian Journal of Surgery
, vol.49
, Issue.4
, pp. 241-244
-
-
Kilic, M.1
Gocmen, E.2
Tez, M.3
Ertan, T.4
Keskek, M.5
Koc, M.6
-
21
-
-
31444447627
-
Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis
-
DOI 10.1016/j.amjsurg.2005.08.029, PII S0002961005007440
-
Tessler DA, Catanzaro A, Velanovich V, et al. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis. Am J Surg 2006;191(2):191-197 (Pubitemid 43151265)
-
(2006)
American Journal of Surgery
, vol.191
, Issue.2
, pp. 191-197
-
-
Tessler, D.A.1
Catanzaro, A.2
Velanovich, V.3
Havstad, S.4
Goel, S.5
-
22
-
-
37849041071
-
Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head
-
Liao Q, Zhao YP, Yang YC, et al. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. Hepatobiliary Pancreat Dis Int 2007;6(6):641-645
-
(2007)
Hepatobiliary Pancreat Dis Int
, vol.6
, Issue.6
, pp. 641-645
-
-
Liao, Q.1
Zhao, Y.P.2
Yang, Y.C.3
-
23
-
-
46949105194
-
TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head
-
Sandblom G, Granroth S, Rasmussen IC. TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. Ups J Med Sci 2008;113(1):57-64
-
(2008)
Ups J Med Sci
, vol.113
, Issue.1
, pp. 57-64
-
-
Sandblom, G.1
Granroth, S.2
Rasmussen, I.C.3
-
24
-
-
33644815924
-
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis
-
DOI 10.1200/JCO.2005.02.8282
-
Gold DV, Modrak DE, Ying Z, et al. New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 2006;24(2):252-258 (Pubitemid 46622054)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.2
, pp. 252-258
-
-
Gold, D.V.1
Modrak, D.E.2
Ying, Z.3
Cardillo, T.M.4
Sharkey, R.M.5
Goldenberg, D.M.6
-
25
-
-
1642475141
-
Inhibition of MUC4 Expression Suppresses Pancreatic Tumor Cell Growth and Metastasis
-
DOI 10.1158/0008-5472.CAN-03-2636
-
Singh AP, Moniaux N, Chauhan SC, et al. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res 2004;64(2):622-630 (Pubitemid 38120902)
-
(2004)
Cancer Research
, vol.64
, Issue.2
, pp. 622-630
-
-
Singh, A.P.1
Moniaux, N.2
Chauhan, S.C.3
Meza, J.L.4
Batra, S.K.5
-
26
-
-
34249878202
-
Mucin expression profile in pancreatic cancer and the precursor lesions
-
DOI 10.1007/s00534-006-1169-2
-
Nagata K, Horinouchi M, Saitou M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg 2007;14(3):243-254 (Pubitemid 46863913)
-
(2007)
Journal of Hepato-Biliary-Pancreatic Surgery
, vol.14
, Issue.3
, pp. 243-254
-
-
Nagata, K.1
Horinouchi, M.2
Saitou, M.3
Higashi, M.4
Nomoto, M.5
Goto, M.6
Yonezawa, S.7
-
27
-
-
47249123007
-
Diagnostic performance of MUC1 for pancreatic ductal adenocarcinoma: A meta-analysis
-
Jiang ZM, Xie DR, Yang Q, et al. Diagnostic performance of MUC1 for pancreatic ductal adenocarcinoma: a meta-analysis. J Clin Oncol (Meeting Abstracts) 2008;26(15S):1568 (Pubitemid 351987492)
-
(2008)
World Chinese Journal of Digestology
, vol.16
, Issue.11
, pp. 1248-1253
-
-
Jiang, Z.-M.1
Yang, Q.2
Chen, D.-L.3
Bi, Z.-F.4
Lin, X.-G.5
Liu, T.-H.6
Li, Z.-H.7
Xie, D.-R.8
-
28
-
-
30744476492
-
Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma
-
Jeong S, Lee DH, Lee JI, et al. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. World J Gastroenterol 2005;11(43):6765-6769 (Pubitemid 43092445)
-
(2005)
World Journal of Gastroenterology
, vol.11
, Issue.43
, pp. 6765-6769
-
-
Jeong, S.1
Lee, D.H.2
Lee, J.I.3
Lee, J.-W.4
Kwon, K.S.5
Kim, P.-S.6
Kim, H.G.7
Shin, Y.W.8
Kim, Y.S.9
Kim, Y.B.10
-
29
-
-
0242329867
-
Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas
-
Stanton KJ, Sidner RA, Miller GA, et al. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am J Surg 2003;186(5):486-492
-
(2003)
Am J Surg
, vol.186
, Issue.5
, pp. 486-492
-
-
Stanton, K.J.1
Sidner, R.A.2
Miller, G.A.3
-
30
-
-
0033991167
-
Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer
-
Itakura J, Ishiwata T, Shen B, et al. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 2000;85(1):27-34
-
(2000)
Int J Cancer
, vol.85
, Issue.1
, pp. 27-34
-
-
Itakura, J.1
Ishiwata, T.2
Shen, B.3
-
31
-
-
37349008544
-
Molecular prognostic factors in patients with pancreatic cancer
-
DOI 10.1517/14728222.11.12.1553
-
Tonini G, Pantano F, Vincenzi B, et al. Molecular prognostic factors in patients with pancreatic cancer. Expert Opin Ther Targets 2007;11(12):1553-1569 (Pubitemid 350285005)
-
(2007)
Expert Opinion on Therapeutic Targets
, vol.11
, Issue.12
, pp. 1553-1569
-
-
Tonini, G.1
Pantano, F.2
Vincenzi, B.3
Gabbrielli, A.4
Coppola, R.5
Santini, D.6
-
32
-
-
20444475238
-
Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups
-
DOI 10.1053/j.gastro.2005.03.006, PII S0016508505003872
-
Yan L, McFaul C, Howes N, et al. Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups. Gastroenterology 2005;128(7):2124- 2130 (Pubitemid 40824719)
-
(2005)
Gastroenterology
, vol.128
, Issue.7
, pp. 2124-2130
-
-
Yan, L.1
McFaul, C.2
Howes, N.3
Leslie, J.4
Lancaster, G.5
Wong, T.6
Threadgold, J.7
Evans, J.8
Gilmore, I.9
Smart, H.10
Lombard, M.11
Neoptolemos, J.12
Greenhalf, W.13
-
33
-
-
52349105475
-
Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens
-
Buchholz M, Kestler H, Gress TM. Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens. Pancreatology 2008;8(6):551-557
-
(2008)
Pancreatology
, vol.8
, Issue.6
, pp. 551-557
-
-
Buchholz, M.1
Kestler, H.2
Gress, T.M.3
-
34
-
-
17844377326
-
Proteomic profiling of pancreatic cancer for biomarker discovery
-
DOI 10.1074/mcp.R500004-MCP200
-
Chen R, Pan S, Brentnall TA, Aebersold R. Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteomics 2005;4(4):523-533 (Pubitemid 40590569)
-
(2005)
Molecular and Cellular Proteomics
, vol.4
, Issue.4
, pp. 523-533
-
-
Chen, R.1
Pan, S.2
Brentnall, T.A.3
Aebersold, R.4
-
35
-
-
59949091318
-
Assessment of soluble angiogenic markers in pancreatic cancer
-
Tanase CP, Raducan E, Dima SO, et al. Assessment of soluble angiogenic markers in pancreatic cancer. Biomarkers Med 2008;5:447-455
-
(2008)
Biomarkers Med
, vol.5
, pp. 447-455
-
-
Tanase, C.P.1
Raducan, E.2
Dima, S.O.3
-
37
-
-
23344438469
-
Circulating vascular endothelial growth factor and interferon-γ- Inducible protein-10 levels in pancreatic cancer during chemotherapy
-
Bellone G, Novarino A, Chiappino I, et al. Circulating vascular endothelial growth factor and interferon-gamma-inducible protein-10 levels in pancreatic cancer during chemotherapy. Anticancer Res 2005;25(5):3287-3291 (Pubitemid 41105202)
-
(2005)
Anticancer Research
, vol.25
, Issue.5
, pp. 3287-3291
-
-
Bellone, G.1
Novarino, A.2
Chiappino, I.3
Gramigni, C.4
Carbone, A.5
Addeo, A.6
Tonel, E.7
Bertetto, O.8
Emanuelli, G.9
-
38
-
-
21344472559
-
Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: Differential diagnosis, tumor progression, and patient survival
-
DOI 10.1097/01.mpa.0000166999.11889.2f
-
Kobayashi A, Yamaguchi T, Ishihara T, et al. Usefulness of plasma vascular endothelial growth factor in the diagnosis of pancreatic carcinoma: differential diagnosis, tumor progression, and patient survival. Pancreas 2005;31(1):74-78 (Pubitemid 40911506)
-
(2005)
Pancreas
, vol.31
, Issue.1
, pp. 74-78
-
-
Kobayashi, A.1
Yamaguchi, T.2
Ishihara, T.3
Ohshima, T.4
Baba, T.5
Shirai, Y.6
Tadenuma, H.7
Nakamura, K.8
Saisho, H.9
-
39
-
-
0034657029
-
High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma
-
DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0. CO;2-V
-
Seo Y, Baba H, Fukuda T, et al. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000;88(10):2239-2245 (Pubitemid 30247122)
-
(2000)
Cancer
, vol.88
, Issue.10
, pp. 2239-2245
-
-
Seo, Y.1
Baba, H.2
Fukuda, T.3
Takashima, M.4
Sugimachi, K.5
-
40
-
-
40449135660
-
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer
-
DOI 10.1373/clinchem.2007.093195
-
Fredriksson S, Horecka J, Brustugun OT, et al. Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer. Clin Chem 2008;54(3):582-589 (Pubitemid 351348153)
-
(2008)
Clinical Chemistry
, vol.54
, Issue.3
, pp. 582-589
-
-
Fredriksson, S.1
Horecka, J.2
Brustugun, O.T.3
Schlingemann, J.4
Koong, A.C.5
Tibshirani, R.6
Davis, R.W.7
-
41
-
-
0037426605
-
Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis
-
DOI 10.1016/S0304-3835(03)00047-8
-
Karayiannakis AJ, Bolanaki H, Syrigos KN, et al. Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis. Cancer Lett 2003;194(1):119-124 (Pubitemid 36428891)
-
(2003)
Cancer Letters
, vol.194
, Issue.1
, pp. 119-124
-
-
Karayiannakis, A.J.1
Bolanaki, H.2
Syrigos, K.N.3
Asimakopoulos, B.4
Polychronidis, A.5
Anagnostoulis, S.6
Simopoulos, C.7
-
42
-
-
0036531923
-
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer
-
Baker CH, Solorzano CC, Fidler IJ. Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 2002;62(7):1996-2003 (Pubitemid 34408443)
-
(2002)
Cancer Research
, vol.62
, Issue.7
, pp. 1996-2003
-
-
Baker, C.H.1
Solorzano, C.C.2
Fidler, I.J.3
-
43
-
-
0038068122
-
Expressions of angiogenic factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival
-
DOI 10.1097/00006676-200305000-00006
-
Kuwahara K, Sasaki T, Kuwada Y, et al. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003;26(4):344-349 (Pubitemid 36529959)
-
(2003)
Pancreas
, vol.26
, Issue.4
, pp. 344-349
-
-
Kuwahara, K.1
Sasaki, T.2
Kuwada, Y.3
Murakami, M.4
Yamasaki, S.5
Chayama, K.6
-
44
-
-
55949086925
-
Serum vascular endothelial growth factor/ soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer
-
Chang YT, Chang MC, Wei SC, et al. Serum vascular endothelial growth factor/ soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas 2008;37(2):145-150
-
(2008)
Pancreas
, vol.37
, Issue.2
, pp. 145-150
-
-
Chang, Y.T.1
Chang, M.C.2
Wei, S.C.3
-
45
-
-
56249140810
-
Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes
-
Lang SA, Schachtschneider P, Moser C, et al. Dual targeting of Raf and VEGF receptor 2 reduces growth and metastasis of pancreatic cancer through direct effects on tumor cells, endothelial cells, and pericytes. Mol Cancer Ther 2008;7(11):3509-3518
-
(2008)
Mol Cancer Ther
, vol.7
, Issue.11
, pp. 3509-3518
-
-
Lang, S.A.1
Schachtschneider, P.2
Moser, C.3
-
46
-
-
0035477337
-
Secreted and cell surface genes expressed in benign and malignant colorectal tumors
-
Buckhaults P, Rago C, St Croix B, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61(19):6996-7001 (Pubitemid 32946484)
-
(2001)
Cancer Research
, vol.61
, Issue.19
, pp. 6996-7001
-
-
Buckhaults, P.1
Rago, C.2
St Croix, B.3
Romans, K.E.4
Saha, S.5
Zhang, L.6
Vogelstein, B.7
Kinzler, K.W.8
-
47
-
-
0037452997
-
Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum
-
Welsh JB, Sapinoso LM, Kern SG, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 2003;100(6):3410-3415
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, Issue.6
, pp. 3410-3415
-
-
Welsh, J.B.1
Sapinoso, L.M.2
Kern, S.G.3
-
48
-
-
11144353917
-
Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic and Other Periampullary Cancers
-
DOI 10.1158/1078-0432.CCR-03-0165
-
Koopmann J, Buckhaults P, Brown DA, et al. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clin Cancer Res 2004;10(7):2386-2392 (Pubitemid 38445697)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.7
, pp. 2386-2392
-
-
Koopmann, J.1
Buckhaults, P.2
Brown, D.A.3
Zahurak, M.L.4
Sato, N.5
Fukushima, N.6
Sokoll, L.J.7
Chan, D.W.8
Yeo, C.J.9
Hruban, R.H.10
Breit, S.N.11
Kinzler, K.W.12
Vogelstein, B.13
Goggins, M.14
-
49
-
-
31544450588
-
Serum markers in patients with resectable pancreatic adenocarcinoma: Macrophage inhibitory cytokine 1 versus CA19-9
-
DOI 10.1158/1078-0432.CCR-05-0564
-
Koopmann J, Rosenzweig CN, Zhang Z, et al. Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res 2006;12(2):442-446 (Pubitemid 43166133)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.2
, pp. 442-446
-
-
Koopmann, J.1
Rosenzweig, C.N.W.2
Zhang, Z.3
Canto, M.I.4
Brown, D.A.5
Hunter, M.6
Yeo, C.7
Chan, D.W.8
Breit, S.N.9
Goggins, M.10
-
50
-
-
2442635516
-
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma
-
Koopmann J, Fedarko NS, Jain A, et al. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2004;13(3):487-491 (Pubitemid 38737477)
-
(2004)
Cancer Epidemiology Biomarkers and Prevention
, vol.13
, Issue.3
, pp. 487-491
-
-
Koopmann, J.1
Fedarko, N.S.2
Jain, A.3
Maitra, A.4
Iacobuzio-Donahue, C.5
Rahman, A.6
Hruban, R.H.7
Yeo, C.J.8
Goggins, M.9
-
51
-
-
33744960940
-
Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer
-
DOI 10.1158/0008-5472.CAN-05-4067
-
Bauskin AR, Brown DA, Kuffner T, et al. Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 2006;66(10):4983-4986 (Pubitemid 43852864)
-
(2006)
Cancer Research
, vol.66
, Issue.10
, pp. 4983-4986
-
-
Bauskin, A.R.1
Brown, D.A.2
Kuffner, T.3
Johnen, H.4
Lou, X.W.5
Hunter, M.6
Breit, S.N.7
-
52
-
-
2442701601
-
Macrophage inhibitory cytokine-1: A novel biomarker for p53 pathway activation
-
Yang H, Filipovic Z, Brown D, et al. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2003;2(10):1023-1029
-
(2003)
Mol Cancer Ther
, vol.2
, Issue.10
, pp. 1023-1029
-
-
Yang, H.1
Filipovic, Z.2
Brown, D.3
-
53
-
-
31544440475
-
Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis
-
DOI 10.1158/1078-0432.CCR-05-1331
-
Brown DA, Stephan C, Ward RL, et al. Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis. Clin Cancer Res 2006;12(1):89-96 (Pubitemid 43166181)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.1
, pp. 89-96
-
-
Brown, D.A.1
Stephan, C.2
Ward, R.L.3
Law, M.4
Hunter, M.5
Bauskin, A.R.6
Amin, J.7
Jung, K.8
Diamandis, E.P.9
Hampton, G.M.10
Russell, P.J.11
Giles, G.G.12
Breit, S.N.13
-
54
-
-
12444303172
-
MIC-1 serum level and genotype: Associations with progress and prognosis of colorectal carcinoma
-
Brown DA, Ward RL, Buckhaults P, et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003;9(7):2642-2650 (Pubitemid 36842108)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.7
, pp. 2642-2650
-
-
Brown, D.A.1
Ward, R.L.2
Buckhaults, P.3
Liu, T.4
Romans, K.E.5
Hawkins, N.J.6
Bauskin, A.R.7
Kinzler, K.W.8
Vogelstein, B.9
Breit, S.N.10
-
55
-
-
33744775945
-
Screening for Early Pancreatic Neoplasia in High-Risk Individuals: A Prospective Controlled Study
-
DOI 10.1016/j.cgh.2006.02.005, PII S1542356506001455
-
Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4(6):766-81; quiz 665 (Pubitemid 43825802)
-
(2006)
Clinical Gastroenterology and Hepatology
, vol.4
, Issue.6
, pp. 766-781
-
-
Canto, M.I.1
Goggins, M.2
Hruban, R.H.3
Petersen, G.M.4
Giardiello, F.M.5
Yeo, C.6
Fishman, E.K.7
Brune, K.8
Axilbund, J.9
Griffin, C.10
Ali, S.11
Richman, J.12
Jagannath, S.13
Kantsevoy, S.V.14
Kalloo, A.N.15
-
56
-
-
34648817383
-
Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy
-
Hathurusinghe HR, Goonetilleke KS, Siriwardena AK. Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol 2007;14(10):2714-2720
-
(2007)
Ann Surg Oncol
, vol.14
, Issue.10
, pp. 2714-2720
-
-
Hathurusinghe, H.R.1
Goonetilleke, K.S.2
Siriwardena, A.K.3
-
57
-
-
58149394924
-
Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer
-
Novotny I, Dite P, Dastych M, et al. Tumor marker M2-pyruvate-kinase in differential diagnosis of chronic pancreatitis and pancreatic cancer. Hepatogastroenterology 2008;55(85):1475-1477
-
(2008)
Hepatogastroenterology
, vol.55
, Issue.85
, pp. 1475-1477
-
-
Novotny, I.1
Dite, P.2
Dastych, M.3
-
58
-
-
4444276517
-
Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer
-
DOI 10.1023/B:DDAS.0000037803.32013.aa
-
Ventrucci M, Cipolla A, Racchini C, et al. Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer. Dig Dis Sci 2004;49(7-8):1149-1155 (Pubitemid 39178081)
-
(2004)
Digestive Diseases and Sciences
, vol.49
, Issue.7-8
, pp. 1149-1155
-
-
Ventrucci, M.1
Cipolla, A.2
Racchini, C.3
Casadei, R.4
Simoni, P.5
Gullo, L.6
-
59
-
-
51849142755
-
Tumor M2 pyruvate kinase: A tumor marker and its clinical application in gastrointestinal malignancy
-
Hardt PD, Ewald N. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy. Expert Rev Mol Diagn 2008;8(5):579-585
-
(2008)
Expert Rev Mol Diagn
, vol.8
, Issue.5
, pp. 579-585
-
-
Hardt, P.D.1
Ewald, N.2
-
60
-
-
34447503504
-
Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis
-
DOI 10.1097/mpa.0b013e3180537237, PII 0000667620070800000002
-
Kumar Y, Gurusamy K, Pamecha V, Davidson BR. Tumor M2-pyruvate kinase as tumor marker in exocrine pancreatic cancer a meta-analysis. Pancreas 2007;35(2):114-119 (Pubitemid 47075564)
-
(2007)
Pancreas
, vol.35
, Issue.2
, pp. 114-119
-
-
Kumar, Y.1
Gurusamy, K.2
Pamecha, V.3
Davidson, B.R.4
-
61
-
-
34248187583
-
CEACAM1, a novel serum biomarker for pancreatic cancer
-
DOI 10.1097/MPA.0b013e3180333ae3, PII 0000667620070500000009
-
Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer. Pancreas 2007;34(4):436-443 (Pubitemid 46725785)
-
(2007)
Pancreas
, vol.34
, Issue.4
, pp. 436-443
-
-
Simeone, D.M.1
Ji, B.2
Banerjee, M.3
Arumugam, T.4
Li, D.5
Anderson, M.A.6
Bamberger, A.M.7
Greenson, J.8
Brand, R.E.9
Ramachandran, V.10
Logsdon, C.D.11
-
62
-
-
34147220062
-
Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker
-
DOI 10.1373/clinchem.2006.079194
-
Melle C, Ernst G, Escher N, et al. Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem 2007;53(4):629-635 (Pubitemid 46580232)
-
(2007)
Clinical Chemistry
, vol.53
, Issue.4
, pp. 629-635
-
-
Melle, C.1
Ernst, G.2
Escher, N.3
Hartmann, D.4
Schimmel, B.5
Bleul, A.6
Thieme, H.7
Kaufmann, R.8
Felix, K.9
Friess, H.M.10
Settmacher, U.11
Hommann, M.12
Richter, K.K.13
Daffner, W.14
Taubig, H.15
Manger, T.16
Claussen, U.17
Von Eggeling, F.18
-
63
-
-
33644926984
-
Clinical utility of quantitative RT-PCR targeted to α1,4-N- acetylglucosaminyltransferase mRNA for detection of pancreatic cancer
-
DOI 10.1111/j.1349-7006.2006.00148.x
-
Ishizone S, Yamauchi K, Kawa S, et al. Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer. Cancer Sci 2006;97(2):119-126 (Pubitemid 43379479)
-
(2006)
Cancer Science
, vol.97
, Issue.2
, pp. 119-126
-
-
Ishizone, S.1
Yamauchi, K.2
Kawa, S.3
Suzuki, T.4
Shimizu, F.5
Harada, O.6
Sugiyama, A.7
Miyagawa, S.8
Fukuda, M.9
Nakayama, J.10
-
64
-
-
0031938490
-
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
-
Mulcahy HE, Lyautey J, Lederrey C, et al. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res 1998;4(2):271-275 (Pubitemid 28122737)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.2
, pp. 271-275
-
-
Mulcahy, H.E.1
Lyautey, J.2
Lederrey, C.3
Chen, X.Q.4
Anker, P.5
Alstead, E.M.6
Ballinger, A.7
Farthing, M.J.G.8
Stroun, M.9
-
65
-
-
17344377380
-
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features
-
Yamada T, Nakamori S, Ohzato H, et al. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Clin Cancer Res 1998;4(6):1527-1532 (Pubitemid 28265239)
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.6
, pp. 1527-1532
-
-
Yamada, T.1
Nakamori, S.2
Ohzato, H.3
Oshima, S.4
Aoki, T.5
Higaki, N.6
Sugimoto, K.7
Akagi, K.8
Fujiwara, Y.9
Nishisho, I.10
Sakon, M.11
Gotoh, M.12
Monden, M.13
-
66
-
-
0041827085
-
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer
-
DOI 10.1067/msy.2003.231
-
Koizumi M, Doi R, Toyoda E, et al. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery 2003;134(2):260-266 (Pubitemid 37070347)
-
(2003)
Surgery
, vol.134
, Issue.2
, pp. 260-266
-
-
Koizumi, M.1
Doi, R.2
Toyoda, E.3
Masui, T.4
Tulachan, S.S.5
Kawaguchi, Y.6
Fujimoto, K.7
Gittes, G.K.8
Imamura, M.9
-
67
-
-
34548418914
-
A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis
-
Babu DA, Deering TG, Mirmira RG. A feat of metabolic proportions: Pdx1 orchestrates islet development and function in the maintenance of glucose homeostasis. Mol Genet Metab 2007;92(1-2):43-55
-
(2007)
Mol Genet Metab
, vol.92
, Issue.1-2
, pp. 43-55
-
-
Babu, D.A.1
Deering, T.G.2
Mirmira, R.G.3
-
68
-
-
48949120875
-
Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas
-
DOI 10.1111/j.1365-2443.2008.01196.x
-
Yoshida T, Shiraki N, Baba H, et al. Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas. Genes Cells 2008;13(7):667-678 (Pubitemid 352003836)
-
(2008)
Genes to Cells
, vol.13
, Issue.7
, pp. 667-678
-
-
Yoshida, T.1
Shiraki, N.2
Baba, H.3
Goto, M.4
Fujiwara, S.5
Kume, K.6
Kume, S.7
-
69
-
-
34250630548
-
Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer
-
Liu T, Gou SM, Wang CY, et al. Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol 2007;13(18):2615-2618 (Pubitemid 46938834)
-
(2007)
World Journal of Gastroenterology
, vol.13
, Issue.18
, pp. 2615-2618
-
-
Liu, T.1
Gou, S.-M.2
Wang, C.-Y.3
Wu, H.-S.4
Xiong, J.-X.5
Zhou, F.6
-
70
-
-
57449083498
-
The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer
-
Quint K, Stintzing S, Alinger B, et al. The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer. Pancreatology 2008;9(1-2):116-126
-
(2008)
Pancreatology
, vol.9
, Issue.1-2
, pp. 116-126
-
-
Quint, K.1
Stintzing, S.2
Alinger, B.3
-
71
-
-
20044388765
-
Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers
-
DOI 10.1007/s00268-004-7823-4
-
Wang XP, Li ZJ, Magnusson J, Brunicardi FC. Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers. World J Surg 2005;29(3):334-338 (Pubitemid 40768046)
-
(2005)
World Journal of Surgery
, vol.29
, Issue.3
, pp. 334-338
-
-
Wang, X.-P.1
Li, Z.-J.2
Magnusson, J.3
Brunicardi, F.C.4
-
72
-
-
55949107920
-
PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer
-
Liu S, Ballian N, Belaguli NS, et al. PDX-1 acts as a potential molecular target for treatment of human pancreatic cancer. Pancreas 2008;37(2):210-220
-
(2008)
Pancreas
, vol.37
, Issue.2
, pp. 210-220
-
-
Liu, S.1
Ballian, N.2
Belaguli, N.S.3
-
73
-
-
34247607335
-
Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: A tissue microarray based study
-
DOI 10.1097/01.pai.0000203037.25791.21, PII 0012903920070300000009
-
Nash JW, Bhardwaj A, Wen P, Frankel WL. Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study. Appl Immunohistochem Mol Morphol 2007;15(1):59-63 (Pubitemid 46673318)
-
(2007)
Applied Immunohistochemistry and Molecular Morphology
, vol.15
, Issue.1
, pp. 59-63
-
-
Nash, J.W.1
Bhardwaj, A.2
Wen, P.3
Frankel, W.L.4
-
74
-
-
0142123394
-
Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas
-
DOI 10.1016/S0304-3835(03)00390-2
-
Ohike N, Maass N, Mundhenke C, et al. Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 2003;199(2):193-200 (Pubitemid 37297712)
-
(2003)
Cancer Letters
, vol.199
, Issue.2
, pp. 193-200
-
-
Ohike, N.1
Maass, N.2
Mundhenke, C.3
Biallek, M.4
Zhang, M.5
Jonat, W.6
Luttges, J.7
Morohoshi, T.8
Kloppel, G.9
Nagasaki, K.10
-
75
-
-
34247382565
-
Prognostic significance of maspin in pancreatic ductal adenocarcinoma: Tissue microarray analysis of 223 surgically resected cases
-
DOI 10.1038/modpathol.3800772, PII 3800772
-
Cao D, Zhang Q, Wu LS, et al. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 2007;20(5):570-578 (Pubitemid 46631999)
-
(2007)
Modern Pathology
, vol.20
, Issue.5
, pp. 570-578
-
-
Cao, D.1
Zhang, Q.2
Wu, L.S.-F.3
Salaria, S.N.4
Winter, J.W.5
Hruban, R.H.6
Goggins, M.S.7
Abbruzzese, J.L.8
Maitra, A.9
Ho, L.10
-
76
-
-
55949135598
-
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma
-
Cohen SJ, Alpaugh RK, Palazzo I, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas 2008;37(2):154-158
-
(2008)
Pancreas
, vol.37
, Issue.2
, pp. 154-158
-
-
Cohen, S.J.1
Alpaugh, R.K.2
Palazzo, I.3
-
77
-
-
18744386654
-
Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma
-
DOI 10.1038/sj.bjc.6600619
-
Suzuoki M, Miyamoto M, Kato K, et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 2002;87(10):1140-1144 (Pubitemid 35418110)
-
(2002)
British Journal of Cancer
, vol.87
, Issue.10
, pp. 1140-1144
-
-
Suzuoki, M.1
Miyamoto, M.2
Kato, K.3
Hiraoka, K.4
Oshikiri, T.5
Nakakubo, Y.6
Fukunaga, A.7
Shichinohe, T.8
Shinohara, T.9
Itoh, T.10
Kondo, S.11
Katoh, H.12
-
78
-
-
67749094835
-
Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma
-
Tanase CP, Dima S, Mihai M, et al. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histol 2009;40(1):23-29
-
(2009)
J Mol Histol
, vol.40
, Issue.1
, pp. 23-29
-
-
Tanase, C.P.1
Dima, S.2
Mihai, M.3
-
79
-
-
53649086945
-
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: Implications for tumor progression and clinical outcome
-
Witkiewicz AK, Nguyen KH, Dasgupta A, et al. Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome. Cell Cycle 2008;7(19):3021-3025
-
(2008)
Cell Cycle
, vol.7
, Issue.19
, pp. 3021-3025
-
-
Witkiewicz, A.K.1
Nguyen, K.H.2
Dasgupta, A.3
-
80
-
-
9744274000
-
Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer
-
DOI 10.1158/1078-0432.CCR-04-1107
-
Mehta K, Fok J, Miller FR, et al. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004;10(23):8068-8076 (Pubitemid 39587548)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.23
, pp. 8068-8076
-
-
Mehta, K.1
Fok, J.2
Miller, F.R.3
Koul, D.4
Sahin, A.A.5
-
81
-
-
42249085070
-
Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells
-
DOI 10.1158/1078-0432.CCR-07-1533
-
Verma A, Guha S, Wang H, et al. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells. Clin Cancer Res 2008;14(7):1997-2005 (Pubitemid 351551108)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.7
, pp. 1997-2005
-
-
Verma, A.1
Guha, S.2
Wang, H.3
Fok, J.Y.4
Koul, D.5
Abbruzzese, J.6
Mehta, K.7
-
82
-
-
35648961927
-
Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas
-
DOI 10.1002/dc.20739
-
Zhao H, Mandich D, Cartun RW, Ligato S. Expression of K homology domain containing protein overexpressed in cancer in pancreatic FNA for diagnosing adenocarcinoma of pancreas. Diagn Cytopathol 2007;35(11):700-704 (Pubitemid 350035041)
-
(2007)
Diagnostic Cytopathology
, vol.35
, Issue.11
, pp. 700-704
-
-
Zhao, H.1
Mandich, D.2
Cartun, R.W.3
Ligato, S.4
-
83
-
-
0037086181
-
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis- associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology
-
Rosty C, Christa L, Kuzdzal S, et al. Identification of hepatocarcinoma-intestine-pancreas/ pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62(6):1868-1875 (Pubitemid 34408515)
-
(2002)
Cancer Research
, vol.62
, Issue.6
, pp. 1868-1875
-
-
Rosty, C.1
Christa, L.2
Kuzdzal, S.3
Baldwin, W.M.4
Zahurak, M.L.5
Carnot, F.6
Chan, D.W.7
Canto, M.8
Lillemoe, K.D.9
Cameron, J.L.10
Yeo, C.J.11
Hruban, R.H.12
Goggins, M.13
-
84
-
-
0042307371
-
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
-
DOI 10.1073/pnas.1133470100
-
Dressman D, Yan H, Traverso G, et al. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci USA 2003;100(15):8817-8822 (Pubitemid 36899181)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.15
, pp. 8817-8822
-
-
Dressman, D.1
Yan, H.2
Traverso, G.3
Kinzler, K.W.4
Vogelstein, B.5
-
85
-
-
13844304889
-
LigAmp for sensitive detection of single-nucleotide differences
-
Shi C, Eshleman SH, Jones D, et al. LigAmp for sensitive detection of single-nucleotide differences. Nat Methods 2004;1(2):141-147
-
(2004)
Nat Methods
, vol.1
, Issue.2
, pp. 141-147
-
-
Shi, C.1
Eshleman, S.H.2
Jones, D.3
-
86
-
-
0036735913
-
Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: Clinical utility for diagnosis of pancreatic tumor
-
DOI 10.1016/S0002-9270(02)04337-X
-
Tada M, Komatsu Y, Kawabe T, et al. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. Am J Gastroenterol 2002;97(9):2263-2270 (Pubitemid 35052042)
-
(2002)
American Journal of Gastroenterology
, vol.97
, Issue.9
, pp. 2263-2270
-
-
Tada, M.1
Komatsu, Y.2
Kawabe, T.3
Sasahira, N.4
Isayama, H.5
Toda, N.6
Shiratori, Y.7
Omata, M.8
-
87
-
-
45849149957
-
High expression of HIF1a is a predictor of clinical outcome in patients with prancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF
-
DOI 10.1593/neo.08292
-
Hoffmann AC, Mori R, Vallbohmer D, et al. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 2008;10(7):674-679 (Pubitemid 351883883)
-
(2008)
Neoplasia
, vol.10
, Issue.7
, pp. 674-679
-
-
Hoffmann, A.-C.1
Mori, R.2
Vallbohmer, D.3
Brabender, J.4
Klein, E.5
Drebber, U.6
Baldus, S.E.7
Cooc, J.8
Azuma, M.9
Metzger, R.10
Hoelscher, A.H.11
Danenberg, K.D.12
Prenzel, K.L.13
Danenberg, P.V.14
-
88
-
-
62549149007
-
CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer
-
Donahue TR, Hines OJ. CXCR2 and RET Single Nucleotide Polymorphisms in Pancreatic Cancer. World J Surg 2008;33(4):710-715
-
(2008)
World J Surg
, vol.33
, Issue.4
, pp. 710-715
-
-
Donahue, T.R.1
Hines, O.J.2
-
89
-
-
53949106060
-
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
-
Casneuf VF, Fonteyne P, Van Damme N, et al. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest 2008;26(8):852-859
-
(2008)
Cancer Invest
, vol.26
, Issue.8
, pp. 852-859
-
-
Casneuf, V.F.1
Fonteyne, P.2
Van Damme, N.3
-
90
-
-
33749364644
-
S100P is an early developmental marker of pancreatic carcinogenesis
-
DOI 10.1158/1078-0432.CCR-06-0298
-
Ohuchida K, Mizumoto K, Egami T, et al. S100P is an early developmental marker of pancreatic carcinogenesis. Clin Cancer Res 2006;12(18):5411-5416 (Pubitemid 44497255)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.18
, pp. 5411-5416
-
-
Ohuchida, K.1
Mizumoto, K.2
Egami, T.3
Yamaguchi, H.4
Fujii, K.5
Konomi, H.6
Nagai, E.7
Yamaguchi, K.8
Tsuneyoshi, M.9
Tanaka, M.10
-
91
-
-
53549129746
-
Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma
-
Jiang NY, Woda BA, Banner BF, et al. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008;17(7):1648-1652
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, Issue.7
, pp. 1648-1652
-
-
Jiang, N.Y.1
Woda, B.A.2
Banner, B.F.3
-
92
-
-
59449096031
-
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation
-
Chen J, Li D, Killary AM, et al. Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation. Ann Surg Oncol 2008;16(2):431-439
-
(2008)
Ann Surg Oncol
, vol.16
, Issue.2
, pp. 431-439
-
-
Chen, J.1
Li, D.2
Killary, A.M.3
-
93
-
-
58149173406
-
Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma
-
Reiser-erkan C, Erkan M, Pan Z, et al. Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther 2008;7(9):1352-1359
-
(2008)
Cancer Biol Ther
, vol.7
, Issue.9
, pp. 1352-1359
-
-
Reiser-erkan, C.1
Erkan, M.2
Pan, Z.3
-
94
-
-
38649104848
-
New markers of pancreatic cancer identified through differential gene expression analyses: Claudin 18 and annexin A8
-
DOI 10.1097/PAS.0b013e31815701f3, PII 0000047820080200000002
-
Karanjawala ZE, Illei PB, Ashfaq R, et al. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol 2008;32(2):188-196 (Pubitemid 351172132)
-
(2008)
American Journal of Surgical Pathology
, vol.32
, Issue.2
, pp. 188-196
-
-
Karanjawala, Z.E.1
Illei, P.B.2
Ashfaq, R.3
Infante, J.R.4
Murphy, K.5
Pandey, A.6
Schulick, R.7
Winter, J.8
Sharma, R.9
Maitra, A.10
Goggins, M.11
Hruban, R.H.12
-
95
-
-
42249105871
-
Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer
-
DOI 10.1158/1078-0432.CCR-07-1520
-
Okazaki T, Jiao L, Chang P, et al. Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clin Cancer Res 2008;14(7):2042-2048 (Pubitemid 351551114)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.7
, pp. 2042-2048
-
-
Okazaki, T.1
Jiao, L.2
Chang, P.3
Evans, D.B.4
Abbruzzese, J.L.5
Li, D.6
-
96
-
-
31544477679
-
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease
-
DOI 10.1158/0008-5472.CAN-05-2664
-
Matsubayashi H, Canto M, Sato N, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006;66(2):1208-1217 (Pubitemid 43165992)
-
(2006)
Cancer Research
, vol.66
, Issue.2
, pp. 1208-1217
-
-
Matsubayashi, H.1
Canto, M.2
Sato, N.3
Klein, A.4
Abe, T.5
Yamashita, K.6
Yeo, C.J.7
Kalloo, A.8
Hruban, R.9
Goggins, M.10
-
97
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008;321(5897):1801-1806
-
(2008)
Science
, vol.321
, Issue.5897
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
-
98
-
-
64849092309
-
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
-
Jones S, Hruban RH, Kamiyama M, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324(5924):217
-
(2009)
Science
, vol.324
, Issue.5924
, pp. 217
-
-
Jones, S.1
Hruban, R.H.2
Kamiyama, M.3
-
99
-
-
26844457138
-
Pancreatic cancer proteome: The proteins that underlie invasion, metastasis, and immunologic escape
-
DOI 10.1053/j.gastro.2005.08.001, PII S0016508505015799
-
Chen R, Yi EC, Donohoe S, et al. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 2005;129(4):1187-1197 (Pubitemid 41446859)
-
(2005)
Gastroenterology
, vol.129
, Issue.4
, pp. 1187-1197
-
-
Chen, R.1
Yi, E.C.2
Donohoe, S.3
Pan, S.4
Eng, J.5
Cooke, K.6
Crispin, D.A.7
Lane, Z.8
Goodlett, D.R.9
Bronner, M.P.10
Aebersold, R.11
Brentnall, T.A.12
-
100
-
-
27744434713
-
Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma
-
DOI 10.1053/j.gastro.2005.08.012, PII S0016508505016331
-
Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 2005;129(5):1454-1463 (Pubitemid 41597388)
-
(2005)
Gastroenterology
, vol.129
, Issue.5
, pp. 1454-1463
-
-
Crnogorac-Jurcevic, T.1
Gangeswaran, R.2
Bhakta, V.3
Capurso, G.4
Lattimore, S.5
Akada, M.6
Sunamura, M.7
Prime, W.8
Campbell, F.9
Brentnall, T.A.10
Costello, E.11
Neoptolemos, J.12
Lemoine, N.R.13
-
101
-
-
31644434206
-
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach
-
DOI 10.1074/mcp.M500178-MCP200
-
Gronborg M, Kristiansen TZ, Iwahori A, et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006;5(1):157-171 (Pubitemid 43169348)
-
(2006)
Molecular and Cellular Proteomics
, vol.5
, Issue.1
, pp. 157-171
-
-
Gronborg, M.1
Kristiansen, T.Z.2
Iwahori, A.3
Chang, R.4
Reddy, R.5
Sato, N.6
Molina, H.7
Jensen, O.N.8
Hruban, R.H.9
Goggins, M.G.10
Maitra, A.11
Pandey, A.12
-
102
-
-
26844512938
-
Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry
-
DOI 10.1021/pr050174l
-
Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. J Proteome Res 2005;4(5):1742-1751 (Pubitemid 41464802)
-
(2005)
Journal of Proteome Research
, vol.4
, Issue.5
, pp. 1742-1751
-
-
Yu, K.H.1
Rustgi, A.K.2
Blair, I.A.3
-
103
-
-
6944239964
-
Diagnosis of pancreatic cancer using serum proteomic profiling
-
DOI 10.1593/neo.04262
-
Bhattacharyya S, Siegel ER, Petersen GM, et al. Diagnosis of pancreatic cancer using serum proteomic profiling. Neoplasia 2004;6(5):674-686 (Pubitemid 39411103)
-
(2004)
Neoplasia
, vol.6
, Issue.5
, pp. 674-686
-
-
Bhattacharyya, S.1
Siegel, E.R.2
Petersen, G.M.3
Chari, S.T.4
Suva, L.J.5
Haun, R.S.6
-
104
-
-
10744223905
-
Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry
-
DOI 10.1158/1078-0432.CCR-1167-3
-
Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10(3):860-868 (Pubitemid 38198884)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.3
, pp. 860-868
-
-
Koopmann, J.1
Zhang, Z.2
White, N.3
Rosenzweig, J.4
Fedarko, N.5
Jagannath, S.6
Canto, M.I.7
Yeo, C.J.8
Chan, D.W.9
Goggins, M.10
-
105
-
-
12944265461
-
Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins
-
Koomen JM, Shih LN, Coombes KR, et al. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 2005;11(3):1110-1118
-
(2005)
Clin Cancer Res
, vol.11
, Issue.3
, pp. 1110-1118
-
-
Koomen, J.M.1
Shih, L.N.2
Coombes, K.R.3
-
106
-
-
33847120804
-
Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling
-
DOI 10.1097/01.mpa.0000250128.57026.b2, PII 0000667620070300000006
-
Ehmann M, Felix K, Hartmann D, et al. Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling. Pancreas 2007;34(2):205-214 (Pubitemid 46294796)
-
(2007)
Pancreas
, vol.34
, Issue.2
, pp. 205-214
-
-
Ehmann, M.1
Felix, K.2
Hartmann, D.3
Schnolzer, M.4
Nees, M.5
Vorderwulbecke, S.6
Bogumil, R.7
Buchler, M.W.8
Friess, H.9
-
107
-
-
38449115230
-
Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas
-
DOI 10.1136/jcp.2006.044735
-
Qi T, Han J, Cui Y, et al. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. J Clin Pathol 2008;61(1):49-58 (Pubitemid 351158225)
-
(2008)
Journal of Clinical Pathology
, vol.61
, Issue.1
, pp. 49-58
-
-
Qi, T.1
Han, J.2
Cui, Y.3
Zong, M.4
Liu, X.5
Zhu, B.6
-
108
-
-
40549087581
-
MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers
-
Cazares LH, Diaz JI, Drake RR, Semmes OJ. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers. Methods Mol Biol 2008;428:125-140
-
(2008)
Methods Mol Biol
, vol.428
, pp. 125-140
-
-
Cazares, L.H.1
Diaz, J.I.2
Drake, R.R.3
Semmes, O.J.4
-
109
-
-
53849144620
-
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
-
Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol 2008;5(10):588-599
-
(2008)
Nat Clin Pract Oncol
, vol.5
, Issue.10
, pp. 588-599
-
-
Kulasingam, V.1
Diamandis, E.P.2
-
110
-
-
50249147732
-
MALDI imaging mass spectrometry for direct tissue analysis: A new frontier for molecular histology
-
Walch A, Rauser S, Deininger SO, Hofler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 2008;130(3):421-434
-
(2008)
Histochem Cell Biol
, vol.130
, Issue.3
, pp. 421-434
-
-
Walch, A.1
Rauser, S.2
Deininger, S.O.3
Hofler, H.4
-
111
-
-
61849093752
-
Pancreatic cancer serum detection using a lectin/glyco-antibody array method
-
Li C, Simeone DM, Brenner DE, et al. Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res 2009;8(2):483-492
-
(2009)
J Proteome Res
, vol.8
, Issue.2
, pp. 483-492
-
-
Li, C.1
Simeone, D.M.2
Brenner, D.E.3
-
112
-
-
65249091988
-
Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells
-
Wu YM, Nowack D, Omenn G, Haab B. Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J Proteome Res 2009;8(4):1876-1886
-
(2009)
J Proteome Res
, vol.8
, Issue.4
, pp. 1876-1886
-
-
Wu, Y.M.1
Nowack, D.2
Omenn, G.3
Haab, B.4
-
113
-
-
33846467633
-
Epidermal growth factor receptor inhibition strategies in pancreatic cancer: Past, present and the future
-
Cohenuram M, Saif MW. Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future. JOP 2007;8(1):4-15 (Pubitemid 46157763)
-
(2007)
Journal of the Pancreas
, vol.8
, Issue.1
, pp. 4-15
-
-
Cohenuram, M.1
Saif, M.W.2
-
114
-
-
41449091030
-
Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis
-
Pham NA, Schwock J, Iakovlev V, et al. Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis. BMC Cancer 2008;8:43
-
(2008)
BMC Cancer
, vol.8
, pp. 43
-
-
Pham, N.A.1
Schwock, J.2
Iakovlev, V.3
-
115
-
-
58149250649
-
Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma
-
Liang JJ, Wang H, Rashid A, et al. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma. Clin Cancer Res 2008;14(21):7043-7049
-
(2008)
Clin Cancer Res
, vol.14
, Issue.21
, pp. 7043-7049
-
-
Liang, J.J.1
Wang, H.2
Rashid, A.3
-
116
-
-
0034813635
-
Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2
-
DOI 10.1006/bbrc.2001.4243
-
Yip-Schneider MT, Lin A, Marshall MS. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun 2001;280(4):992-997 (Pubitemid 32924437)
-
(2001)
Biochemical and Biophysical Research Communications
, vol.280
, Issue.4
, pp. 992-997
-
-
Yip-Schneider, M.T.1
Lin, A.2
Marshall, M.S.3
-
117
-
-
33747885206
-
Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer
-
DOI 10.1158/0008-5472.CAN-06-1019
-
Wang Z, Sengupta R, Banerjee S, et al. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer. Cancer Res 2006;66(15):7653-7660 (Pubitemid 44289223)
-
(2006)
Cancer Research
, vol.66
, Issue.15
, pp. 7653-7660
-
-
Wang, Z.1
Sengupta, R.2
Banerjee, S.3
Li, Y.4
Zhang, Y.5
Wahidur Rahman, K.M.6
Aboukameel, A.7
Mohammad, R.8
Majumdar, A.P.N.9
Abbruzzese, J.L.10
Sarkar, F.H.11
-
118
-
-
49249095430
-
Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells
-
Zhao S, Venkatasubbarao K, Lazor JW, et al. Inhibition of STAT3 Tyr705 phosphorylation by Smad4 suppresses transforming growth factor beta-mediated invasion and metastasis in pancreatic cancer cells. Cancer Res 2008;68(11):4221-4228
-
(2008)
Cancer Res
, vol.68
, Issue.11
, pp. 4221-4228
-
-
Zhao, S.1
Venkatasubbarao, K.2
Lazor, J.W.3
-
119
-
-
33845524970
-
Transforming growth factor-β in cancer and metastasis
-
DOI 10.1007/s10555-006-9006-2, Special Issue on Pro-inflammatory Cytokines in Cancer
-
Jakowlew SB. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006;25(3):435-457 (Pubitemid 44922360)
-
(2006)
Cancer and Metastasis Reviews
, vol.25
, Issue.3
, pp. 435-457
-
-
Jakowlew, S.B.1
-
120
-
-
33645075720
-
Hedgehog signaling in pancreas development and disease
-
Lau J, Kawahira H, Hebrok M. Hedgehog signaling in pancreas development and disease. Cell Mol Life Sci 2006;63(6):642-652
-
(2006)
Cell Mol Life Sci
, vol.63
, Issue.6
, pp. 642-652
-
-
Lau, J.1
Kawahira, H.2
Hebrok, M.3
-
121
-
-
34547830895
-
β-Catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer
-
DOI 10.1016/j.mehy.2007.01.069, PII S0306987707001545
-
Wang Z, Ma Q. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer. Med Hypotheses 2007;69(4):816-820 (Pubitemid 47248125)
-
(2007)
Medical Hypotheses
, vol.69
, Issue.4
, pp. 816-820
-
-
Wang, Z.1
Ma, Q.2
-
122
-
-
45949086825
-
Surrogate biomarkers in evaluating response to anti-angiogenic agents: Focus on sunitinib
-
Deprimo SE, Bello C. Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib. Ann Oncol 2007;18(Suppl 10):x11-19
-
(2007)
Ann Oncol
, vol.18
, Issue.SUPPL. 10
-
-
Deprimo, S.E.1
Bello, C.2
-
123
-
-
34547779489
-
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: Modulation of VEGF and VEGF-related proteins
-
DOI 10.1186/1479-5876-5-32
-
Deprimo SE, Bello CL, Smeraglia J, et al. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl Med 2007;5:32 (Pubitemid 47226331)
-
(2007)
Journal of Translational Medicine
, vol.5
, pp. 32
-
-
Deprimo, S.E.1
Bello, C.L.2
Smeraglia, J.3
Baum, C.M.4
Spinella, D.5
Rini, B.I.6
Dror, M.D.7
Motzer, R.J.8
-
124
-
-
27644549557
-
Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies
-
DOI 10.1097/01.mpa.0000175893.04660.1b
-
Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 2005;31(4):301-316 (Pubitemid 41566878)
-
(2005)
Pancreas
, vol.31
, Issue.4
, pp. 301-316
-
-
Mimeault, M.1
Brand, R.E.2
Sasson, A.A.3
Batra, S.K.4
|